Gabapentin and Burning feet syndrome - a phase IV clinical study of FDA data
Burning feet syndrome is found among people who take Gabapentin, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Gabapentin and have Burning feet syndrome. It is created by eHealthMe based on reports of 292,819 people who have side effects when taking Gabapentin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
292,819 people reported to have side effects when taking Gabapentin.
Among them, 17 people (0.01%) have Burning feet syndrome.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 273,741 Gabapentin users for its effectiveness, alternative drugs and more.
What is Burning feet syndrome?
Burning feet syndrome (burning sensation in the sole of the foot) is found to be associated with 254 drugs and 218 conditions by eHealthMe.
Number of Gabapentin and Burning feet syndrome reports submitted per year:
Gender of people who have Burning feet syndrome when taking Gabapentin *:
- female: 50 %
- male: 50 %
Age of people who have Burning feet syndrome when taking Gabapentin *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 20 %
- 30-39: 0.0 %
- 40-49: 10 %
- 50-59: 20 %
- 60+: 50 %
Common drugs people take besides Gabapentin *:
- Vitamin D3: 6 people, 35.29%
- Lipitor: 4 people, 23.53%
- Vitamin C: 4 people, 23.53%
- Fluoxetine: 4 people, 23.53%
- Metrogel: 4 people, 23.53%
- Jakafi: 4 people, 23.53%
- Soma: 4 people, 23.53%
- Vitamin B12: 4 people, 23.53%
- Melatonin: 4 people, 23.53%
- Medrol: 4 people, 23.53%
Common side effects people have besides Burning feet syndrome *:
- Fatigue (feeling of tiredness): 8 people, 47.06%
- Pain In Extremity: 8 people, 47.06%
- Headache (pain in head): 8 people, 47.06%
- Feeling Abnormal: 7 people, 41.18%
- Nausea (feeling of having an urge to vomit): 7 people, 41.18%
- Hyperaesthesia: 6 people, 35.29%
- Dizziness: 6 people, 35.29%
- Photosensitivity Reaction: 6 people, 35.29%
- Diplopia (double vision): 6 people, 35.29%
- Nosebleed (bleeding from nose): 5 people, 29.41%
Common conditions people have *:
- Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 23.53%
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 23.53%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
- Infection: 2 people, 11.76%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.88%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.88%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
- Insomnia (sleeplessness): 1 person, 5.88%
- Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 5.88%
- Depression: 1 person, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Burning feet syndrome?Check whether Burning feet syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How severe was Burning feet syndrome and when was it recovered:
Expand to all the drugs that have ingredients of gabapentin:
Alternative drugs to, pros and cons of Gabapentin:
- Gabapentin (273,741 reports)
Common Gabapentin side effects:
- Drug ineffective: 21,488 reports
- Fatigue (feeling of tiredness): 21,158 reports
- Pain: 17,075 reports
- Diarrhea: 14,241 reports
- Dizziness: 13,438 reports
- Headache (pain in head): 13,437 reports
Browse all side effects of Gabapentin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Burning feet syndrome treatments and more:
- Burning feet syndrome (472 reports)
COVID vaccines that are related to Burning feet syndrome:
- Burning feet syndrome in Moderna COVID Vaccine
- Burning feet syndrome in Pfizer BioNTech Covid Vaccine
- Burning feet syndrome in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Burning feet syndrome:
- Burning feet syndrome (254 drugs)
All the conditions that are associated with Burning feet syndrome:
- Burning feet syndrome (218 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pain and Feeding Disorder - 2 seconds ago
- Implant Site Pain and drugs of ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e - 8 seconds ago
- Groin Pain and drugs of ingredients of troglitazone - 20 seconds ago
- Alprostadil and Oxybutynin Chloride drug interaction - 20 seconds ago
- Humulin R and Robinul drug interaction - 25 seconds ago
- Clarithromycin and Sleep Disorder - 27 seconds ago
- Atrial Fibrillation/Flutter and drugs of ingredients of emtricitabine; tenofovir disoproxil fumarate - 40 seconds ago
- Clorazepate Dipotassium and Atrioventricular Block Second Degree - 46 seconds ago
- Renal Failure - Acute in Golytely, how severe and when it was recovered? - 46 seconds ago
- Acute Kidney Failure in Golytely, how severe and when it was recovered? - 46 seconds ago